Revenue, last year
€797M
+2% vs prior year
Net income
−€196.1M
−133.7% vs prior year
EPS, diluted
−€1.11
−136.2% vs prior year
Operating cash flow
€18.2M
−50% vs prior year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY24 | €797M | −€196.1M |
| FY23 | €781.4M | −€83.9M |
| FY22 | €751.4M | −€175.7M |
| FY21 | €618M | €215.5M |
| FY20 | €500.9M | €6.3M |
| FY19 | €446.4M | €38.2M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY24 | 14.4% | −17.9% | −24.6% |
| FY23 | 22.4% | −6.1% | −10.7% |
| FY22 | 23.2% | 2.8% | −23.4% |
| FY21 | 24.5% | 6.6% | 34.9% |
| FY20 | 25.1% | 9.7% | 1.3% |
| FY19 | 29.8% | 14% | 8.5% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY24 | −€99.2M |
| FY23 | −€176.9M |
| FY22 | €24.5M |
| FY21 | €7.7M |
| FY20 | −€54.4M |
| FY19 | €10.9M |
| FY18 | - |
- Evotec
- Healthcare median
Show the numbers
| Year | Evotec | Healthcare median |
|---|---|---|
| FY24 | −24.6% | −47% |
| FY23 | −10.7% | −58% |
| FY22 | −23.4% | −80.4% |
| FY21 | 34.9% | −71.8% |
| FY20 | 1.3% | −62.2% |
| FY19 | 8.5% | −46.2% |
| FY18 | - | −49.6% |